All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells
2020 · BMC Cancer · 52 citations
https://doi.org/10.1186/s12885-020-06818-0
L
Liyang Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
132
Papers
3.6K
Citations
35
h-index
64
i10-index
Liyang Wang is an academic researcher from Cambridge University Hospitals NHS Foundation Trust. The author has contributed to research in topics: Computational Drug Discovery Methods & AI in cancer detection & Radiomics and Machine Learning in Medical Imaging. The author has an h-index of 35, co-authored 113 publications.
ORCID: 0000-0002-6175-9219Papers by this author
worksSystemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE−/− mice by modulating autophagy, foam cell formation and immune-negative molecules
2016 · Cell Death and Disease · 50 citations
https://doi.org/10.1038/cddis.2016.376
Development and prospect of telemedicine
2022 · Intelligent Medicine · 43 citations
https://doi.org/10.1016/j.imed.2022.10.004
Multimodal-based machine learning strategy for accurate and non-invasive prediction of intramedullary glioma grade and mutation status of molecular markers: a retrospective study
2023 · BMC Medicine · 31 citations
https://doi.org/10.1186/s12916-023-02898-4
Machine learning discovery of novel antihypertensive peptides from highland barley protein inhibiting angiotensin I-converting enzyme (ACE)
2025 · Food Research International · 22 citations
https://doi.org/10.1016/j.foodres.2025.115689
Autophagy in High-Fat Diet and Streptozotocin-Induced Metabolic Cardiomyopathy: Mechanisms and Therapeutic Implications
2025 · International Journal of Molecular Sciences · 8 citations
https://doi.org/10.3390/ijms26041668
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat